Advertisement
BDX vs MMSI
Which Stock Would AI Choose? Becton, Dickinson and Company (BDX) vs. Merit Medical Systems, Inc. (MMSI) Stock Comparison
Key Takeaways
- BDX (Becton, Dickinson and Company) operates as a larger, diversified medical technology firm with broader exposure across diagnostics, devices, and pharmaceutical systems, while MMSI (Merit Medical Systems, Inc.) focuses on specialized interventional and diagnostic products.
- In recent market activity, BDX has shown relative stability with modest year-to-date gains amid ongoing restructuring and upcoming earnings, contrasting with MMSI's more pronounced year-to-date price adjustment from earlier levels.
- Sector sentiment for both remains tied to healthcare utilization trends and product innovation, with BDX navigating leadership transitions and MMSI preparing for its second-quarter results.
- Market capitalization places BDX in the large-cap category at approximately $43 billion, versus MMSI as a mid-cap name near $4.4 billion, highlighting differences in scale and liquidity.
- Analyst coverage for MMSI reflects a consensus moderate buy with higher price targets relative to recent trading levels, while BDX maintains steady institutional interest amid earnings expectations.
- Relative performance in recent weeks underscores trade-offs between BDX's defensive profile in medical technology and MMSI's potential for targeted growth in procedural products.
Introduction
Investors and traders seeking to evaluate opportunities within the medical technology sector often compare established leaders with specialized innovators. BDX and MMSI represent two distinct profiles in this space: one a broad-based provider of essential healthcare products and the other a focused developer of interventional solutions. This comparison appeals to those assessing relative performance, sector exposure, and positioning in a market environment shaped by healthcare demand trends and earnings cycles. Market participants monitoring stability versus growth potential may find the analysis useful for portfolio allocation decisions.
BDX Overview and Recent Performance
Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents used in healthcare settings worldwide. Its portfolio spans medication management, diagnostics, and surgical solutions. In recent market activity, shares have traded with relative stability near $156, reflecting modest year-to-date gains amid broader healthcare sector movements. Key influences include ongoing restructuring efforts, leadership transitions, and preparation for fiscal third-quarter results expected in early August. Sentiment has been shaped by mixed earnings expectations and adjustments related to prior business divestitures, contributing to a measured performance profile compared with market benchmarks.
MMSI Overview and Recent Performance
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical devices for interventional and diagnostic procedures. Its products serve cardiology, radiology, and endoscopy applications. In recent market activity, shares have hovered near $74 following year-to-date price adjustments from higher opening levels earlier in the period. Influences include anticipation of second-quarter earnings scheduled for late July and analyst commentary on product expansion and operational execution. Sentiment reflects a balance of growth in core segments against broader market pressures, resulting in performance that has varied relative to major indices in recent weeks.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing automated trading strategies from a platform offering hundreds of AI trading bots that execute across thousands of different tickers. Only those demonstrating strong alignment with prevailing market conditions, consistent risk-adjusted metrics, and adaptability across varying timeframes earn placement in the trending section. Available bots encompass diverse trading styles, strategies, and statistical profiles, with performance data spanning multiple periods and asset classes. This resource provides traders with transparent access to backtested results and live signals. Explore the Trending AI Robots page for detailed bot specifications and suitability assessments.
Head-to-Head Comparison
BDX and MMSI differ markedly in business scale and model. BDX delivers a diversified suite of medical technology solutions with global reach, supporting recurring revenue streams in essential care areas, whereas MMSI concentrates on specialized, single-use devices that benefit from procedural volume growth. Recent momentum has favored BDX with steadier price behavior, while MMSI has experienced greater volatility tied to quarterly updates. Risk factors include BDX’s exposure to regulatory and integration challenges from restructuring, contrasted with MMSI’s sensitivity to reimbursement shifts and competition in interventional markets. Sector exposure remains healthcare-centric for both, though BDX offers broader defensive characteristics and MMSI aligns more closely with elective procedure trends. Market sentiment appears constructive for MMSI via analyst targets, while BDX benefits from established institutional positioning amid earnings cycles.
Tickeron AI Verdict
Based on observable factors including trend consistency, earnings positioning, and relative market stability, Tickeron’s AI models currently assign a modest probabilistic preference to BDX. Its larger scale and diversified revenue base provide a buffer during periods of sector uncertainty, with upcoming results offering a clear catalyst for reassessment. MMSI presents compelling growth attributes through product focus but carries higher sensitivity to quarterly execution. The assessment remains conditional on evolving market data and does not constitute investment guidance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and MMSI is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 2 FA rating(s) are green whileMMSI’s FA Score has 0 green FA rating(s).
- BDX’s FA Score: 2 green, 3 red.
- MMSI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 5 TA indicator(s) are bullish while MMSI’s TA Score has 3 bullish TA indicator(s).
- BDX’s TA Score: 5 bullish, 4 bearish.
- MMSI’s TA Score: 3 bullish, 4 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +3.70% price change this week, while MMSI (@Pharmaceuticals: Other) price change was +1.93% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.26%. For the same industry, the average monthly price growth was +8.63%, and the average quarterly price growth was +6.97%.
Reported Earning Dates
BDX is expected to report earnings on Nov 05, 2026.
MMSI is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.26% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| BDX | MMSI | BDX / MMSI | |
| Capitalization | 50B | 5.42B | 923% |
| EBITDA | 4.97B | 362M | 1,373% |
| Gain YTD | 21.791 | 2.973 | 733% |
| P/E Ratio | 31.73 | 37.35 | 85% |
| Revenue | 22.2B | 1.58B | 1,406% |
| Total Cash | N/A | 449M | - |
| Total Debt | 17.3B | 820M | 2,110% |
BDX | MMSI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 33 | 48 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 89 | 65 | |
SMR RATING 1..100 | 86 | 74 | |
PRICE GROWTH RATING 1..100 | 14 | 39 | |
P/E GROWTH RATING 1..100 | 62 | 65 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDX's Valuation (7) in the Medical Specialties industry is somewhat better than the same rating for MMSI (69). This means that BDX’s stock grew somewhat faster than MMSI’s over the last 12 months.
MMSI's Profit vs Risk Rating (65) in the Medical Specialties industry is in the same range as BDX (89). This means that MMSI’s stock grew similarly to BDX’s over the last 12 months.
MMSI's SMR Rating (74) in the Medical Specialties industry is in the same range as BDX (86). This means that MMSI’s stock grew similarly to BDX’s over the last 12 months.
BDX's Price Growth Rating (14) in the Medical Specialties industry is in the same range as MMSI (39). This means that BDX’s stock grew similarly to MMSI’s over the last 12 months.
BDX's P/E Growth Rating (62) in the Medical Specialties industry is in the same range as MMSI (65). This means that BDX’s stock grew similarly to MMSI’s over the last 12 months.
| BDX | MMSI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | 1 day ago 61% |
| Stochastic ODDS (%) | 1 day ago 46% | 1 day ago 58% |
| Momentum ODDS (%) | 1 day ago 50% | N/A |
| MACD ODDS (%) | 1 day ago 51% | 1 day ago 68% |
| TrendWeek ODDS (%) | 1 day ago 47% | 1 day ago 59% |
| TrendMonth ODDS (%) | 1 day ago 50% | 1 day ago 57% |
| Advances ODDS (%) | 4 days ago 44% | 4 days ago 65% |
| Declines ODDS (%) | 24 days ago 43% | 25 days ago 57% |
| BollingerBands ODDS (%) | 1 day ago 50% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 53% |
Advertisement
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +0.79% | ||
| COO - BDX | 54% Loosely correlated | -0.56% | ||
| BAX - BDX | 51% Loosely correlated | -1.18% | ||
| TMO - BDX | 50% Loosely correlated | -1.28% | ||
| CNMD - BDX | 48% Loosely correlated | +1.18% | ||
| SOLV - BDX | 47% Loosely correlated | +2.46% | ||
More | ||||
MMSI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To MMSI | 1D Price Change % | ||
|---|---|---|---|---|
| MMSI | 100% | +0.29% | ||
| BSX - MMSI | 56% Loosely correlated | +0.27% | ||
| SYK - MMSI | 50% Loosely correlated | -0.55% | ||
| ICUI - MMSI | 49% Loosely correlated | -0.07% | ||
| COO - MMSI | 46% Loosely correlated | -0.56% | ||
| BDX - MMSI | 44% Loosely correlated | +0.79% | ||
More | ||||